Inventor · Belmont, CA, US

Christopher Carreras

27Patents
6h-index
31Co-inventors
69Inventor score

Filing activity: Feb 15, 2001 → Apr 1, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US6562795B2 Motilide compounds Human Necessities 19 Expired
US8815910B2 Compounds and methods for inhibiting phosphate transport Chemistry; Metallurgy 7 Active
US8815908B2 Compounds and methods for inhibiting phosphate transport Chemistry; Metallurgy 7 Active
US8809339B2 Compounds and methods for inhibiting phosphate transport Chemistry; Metallurgy 7 Active
US9408840B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder Emerging Cross-Sectional Technologies 6 Active
US7211568B2 9-Desoxoerythromycin compounds as prokinetic agents Human Necessities 6 Expired
US8916569B2 Compounds and methods for inhibiting phosphate transport Chemistry; Metallurgy 5 Active
US10272079B2 NHE3-binding compounds and methods for inhibiting phosphate transport Human Necessities 5 Active
US8541448B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Emerging Cross-Sectional Technologies 4 Active
US10376481B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Human Necessities 3 Active
US6875576B2 Method for evaluating therapeutic efficacy Physics 3 Expired
US6946482B2 Motilide compounds Chemistry; Metallurgy 3 Expired
US10543207B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Emerging Cross-Sectional Technologies 3 Active
US8969377B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Emerging Cross-Sectional Technologies 2 Active
US6750205B2 Motilide compounds Human Necessities 2 Expired
US10385024B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Emerging Cross-Sectional Technologies 2 Active
US11318129B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Emerging Cross-Sectional Technologies 1 Active
US9006281B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Emerging Cross-Sectional Technologies 1 Active
US10940146B2 NHE3-binding compounds and methods for inhibiting phosphate transport Human Necessities 1 Active
US11813304B2 Compounds and methods for inhibiting phosphate transport Physics 0 Active
US9289429B2 Compounds and methods for inhibiting phosphate transport Chemistry; Metallurgy 0 Active
US9301951B2 Compounds and methods for inhibiting phosphate transport Chemistry; Metallurgy 0 Active
US7407941B2 N-desmethyl-N-substituted-11-deoxyerythromycin compounds Human Necessities 0 Expired
US9289430B2 Compounds and methods for inhibiting phosphate transport Chemistry; Metallurgy 0 Active
US12016856B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.